Publications

5491 Results

The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium

Authors
A Rodday;S Parsons;J Upshaw;JW Friedberg;A Gallamini;E Hawkes;D Hodgson;P Johnson;B Link;E Mou;K Savage;P Zinzani;M Mauer;A Evens
Journal / Conference
J Clin Oncol. Apr 10;41(11):2076-2086
Year
2023
Research Committee(s)
Lymphoma
PMID
PMID36495588
PMC
PMC10082254
Study Number(s)
S0816

Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial

Authors
A VanderWalde;S Bellasea;K Kendra;N Khushalani;K Campbell;P Scumpia;L Kuklinski;F Collichio;J Sosman;A Ikeguchi;A Victor;T Truong;B Chmielowski;D Portnoy;Y Chen;K Margolin;C Bane;C Dasanu;D Johnson;Z Eroglu;S Chandra;E Medini;C Gonzalez;I Baselga Carretero;A Vega-Crespo;I Perez Garciliazo;E Sharon;S Hu-Lieskovan;S Patel;K Grossmann;J Moon;M Wu;A Ribas
Journal / Conference
Nature Medicine Sep;29(9):2278-2285
Year
2023
Research Committee(s)
Melanoma
PMID
PMID37592104
PMC
PMCID10708907
Study Number(s)
S1616

The Medicaid Expansion of the Affordable Care Act and the Participation of Patients with Medicaid in Cancer Clinical Trials

Authors
J Unger;H Xiao;R Vaidya;M LeBlanc;D Hershman
Journal / Conference
JAMA Oncology Oct 1;9(10):1371-1379
Year
2023
Research Committee(s)
Cancer Care Delivery
PMID
PMID37590003
PMC
PMC10436183

Phase II Trial of Atezolizumab in BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer: SWOG S1605

Authors
P Black;C Tangen;P Singh;D McConkey;MS Lucia;W Lowrance;V Koshkin;K Stratton;T Bivalacqua;W Kassouf;S Porten;R Bangs;M Plets;IM Thompson;SP Lerner
Journal / Conference
European Urology Aug 16;S0302-2838(23)03019-1. doi: 10.1016/j.eururo.2023.08.004. Online ahead of print
Year
2023
Research Committee(s)
Genitourinary
PMID
PMID37596191
PMC
PMC10869634
Study Number(s)
S1605

Impact of race on treatment outcomes of patients with metastatic castration-sensitive prostate cancer receiving intensified androgen deprivation therapy: A post hoc analysis of the SWOG 1216 phase III trial

Authors
N Sayegh;U Swami;Y Jo;G Gebrael;B Haaland;S Gupta;M Plets;M Hussain;D Quinn;P Lara;I Thompson;N Agarwal
Journal / Conference
JAMA Netw Open Aug 1;6(8):e2326546
Year
2023
Research Committee(s)
Genitourinary
PMID
PMID37526936
PMC
PMC10394570
Study Number(s)
S1216

Assessment of Financial Screening and Navigation Capabilities at NCI Community Oncology Clinics

Authors
A Bell-Brown;K Watabayashi;D Delaney;R Carlos;S Langer;J Unger;R Vaidya;A Darke;D Hershman;S Ramsey;V Shankaran
Journal / Conference
JNCI Cancer Spectrum Aug 31;7(5):pkad055. doi: 10.1093/jncics/pkad055
Year
2023
Research Committee(s)
Cancer Care Delivery
PMID
PMID37561111
PMC
PMC10471524
Study Number(s)
S1912CD

Effects of CYP3A4 and CYP2C9 genotype on systemic anastrozole and fulvestrant concentrations in SWOG S0226

Authors
D Rutherford;S Medley;N Henderson;C Gersch;T Vandenberg;K Albain;S Dakhil;N Tirumali;J Gralow;G Hortobagyi;L Pusztai;R Mehta;D Hayes;K Kidwell;NL Henry;W Barlow;J Rae;D Hertz
Journal / Conference
Pharmacogenomics Aug;24(12):665-673
Year
2023
Research Committee(s)
Breast
PMID
PMID37615099
PMC
PMC10565537
Study Number(s)
S0226

Combination of talimogene laherparepvec (T-VEC) with pembrolizumab (pembro) in advanced melanoma patients following progression on a prior PD-1 inhibitor: SWOG S1607

Authors
S Hu-Lieskovan;J Moon;J Hyngstrom;K Campbell;G In;T Logan;K Kendra;D Wang;D Johnson;G Doolittle;A Tan;Ann Silk;K Grossmann;C Ryan;SP Patel;S Bellasea;M Wu;J Kirkwood;H Chen;A Ribas
Journal / Conference
AACR Annual Meeting (April 14-19, 2023, Orlando, FL, poster; Cancer Research Volume 83, Issue 7_Supplement 1 April 2023
Year
2023
Research Committee(s)
Melanoma
Study Number(s)
S1607

Representativeness of Patients Enrolled in the Lung Cancer Master Protocol (Lung-MAP)

Authors
R Vaidya;J Unger;L Qian;K Minichiello;R Herbst;D Gandara;J Neal;T Leal;J Patel;K Dragnev;S Waqar;M Edelman;E Sigal;S Adam;S Malik;C Blanke;M LeBlanc;K Kelly;J Gray;M Redman
Journal / Conference
JCO Precision Oncology Sep;7:e2300218
Year
2023
Research Committee(s)
Lung
PMID
PMID37677122
Study Number(s)
LUNGMAP

An analysis of the rate of second primary lung cancer from CALGB/Alliance 140503 trial of lobar versus sub-lobar resection for T1aN0 NSCLC

Authors
T Stinchcombe;X Wang;B Damman;J Mentlick;R Landreneau;D Wigle;D Jones;M Conti;A Ashrafi;M Liberman;M DePerrot;J Mitchell;R Keenan;T Bauer;D Miller;N Altorki
Journal / Conference
WCLC (September 9 to 12, 2023, Singapore), oral presentation #OA12.03
Year
2023
Research Committee(s)
Lung